Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Dec 15, 2022; 14(12): 2329-2339
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2329
Published online Dec 15, 2022. doi: 10.4251/wjgo.v14.i12.2329
Figure 4 Exploring the relationship between nucleus accumbens-1, programmed death receptor-1 ligand and CD8 at the clinical level.
A: Nucleus accumbens-1 (NAC-1), programmed death receptor-1 ligand (PD-L1), and CD8 staining results of typical tissue samples from several patients, scale bar = 50 μm; B: NAC-1 expression in tumor tissues and adjacent tissues; C: PD-L1 expression in tumor tissues and adjacent tissues; D: The expression of CD8 in tumor tissues and adjacent tissues. NAC-1: Nucleus accumbens-1.
- Citation: Shen ZH, Luo WW, Ren XC, Wang XY, Yang JM. Expression of nucleus accumbens-1 in colon cancer negatively modulates antitumor immunity. World J Gastrointest Oncol 2022; 14(12): 2329-2339
- URL: https://www.wjgnet.com/1948-5204/full/v14/i12/2329.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i12.2329